Year 2021 / Volume 113 / Number 12
Editorial
Cases of liver disease lost in the health system: a call to action

807-809

DOI: 10.17235/reed.2021.8316/2021

Antonio Olveira, Manuel Hernández-Guerra, Esther Molina,

Abstract
We recently reported our experience searching for patients with primary biliary cholangitis (PBC) who were lost in the health system. Our search of databases in 4 hospitals, 3 of which were tertiary institutions, revealed that sufficient data were available to ensure a reliable diagnosis (i.e., cholestasis, positive antimitochondrial antibody titer, and no other liver disease) in 14.3 % (100/697) of PBC cases. However, patients remained undiagnosed, thus missing an opportunity to start early treatment and follow-up. Even more strikingly, of 30 rescued patients, 27 % had an elastography result indicating a poorer prognosis (> 9.5 kPa).
Share Button
New comment
Comments
No comments for this article
References
2. Andaluz I, Arcos MM, Montero MD, et al. Pacientes con hepatitis C perdidos en el sistema: aspectos éticos-legales y resultados de su búsqueda. Rev Esp Enferm Dig 2020;112:532-7.
3. Morales-Arráez D, Alonso-Larruga A, Díaz-Flores F, et al. Predictive factors for not undergoing RNA testing in patients found to have hepatitis C serology and impact of an automatic alert. J Viral Hepat 2019;26:1117-23.
4. Ruiz-Ramírez MA, Urteaga C, Díaz-Sánchez A, et al. Enfermedad hepática por déficit de alfa-1 antitripsina: pacientes perdidos en el sistema. Gastroenterol Hepatol 2020;43(Espec Congr 1):106 (póster 152).
5. Morales-Arráez D, Nieto Bujalance Y, Díaz-Flores F, et al. Risk of liver fibrosis progression in patients with suboptimal diagnosis of hepatitis C virus infection. Eur J Gastroenterol Hepatol 2020;32:528-34.
6. Morales-Arráez D, Díaz-Flores F, Alonso A, et al. Patients with suboptimal hepatitis B virus diagnostic characterization are at risk of liver fibrosis progression. Eur J Gastroenterol Hepatol 2020;32:426-32.
7. Nouch S, Gallagher L, Erickson M, et al. Factors associated with lost to follow-up after hepatitis C treatment delivered by primary care teams in an inner-city multi-site program, Vancouver, Canada. International Journal of Drug Policy 2018;59:76–84.
8. Darvishian M, Wong S, Binka M, et al. Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies. J Viral Hepat 2020;27:243-60.
9. Beekmans N, Klemt-Kropp M. Re-evaluation of chronic hepatitis B and hepatitis C patients lost to follow-up: results of the Northern Holland hepatitis retrieval project. Hepatology, Medicine and Policy 2018;3:1–6.
10. Simpson H, Manley P, Lawler J, et al. Distance to treatment as a factor for loss to follow up of hepatitis C patients in North East England. Journal of Public Health (United Kingdom) 2019;41:700–6.
11. Kracht PAM, Arends JE, van Erpecum KJ, et al. REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province. Liver International 2019; 39:455–62.
12. Morales-Arráez D, Hernández-Guerra M. Electronic alerts as a simple method for amplifying the yield of hepatitis C virus infection screening and diagnosis. Am J Gastroenterol 2020;115:9-12.
13. Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y Garantía de los Derechos Digitales. BOE núm. 294, de 6 de diciembre de 2018, páginas 119788 a 119857.
14. Reglamento (UE) 2016/679 del Parlamento Europeo y del Consejo de 27 de abril de 2016, relativo a la protección de las personas físicas en lo que respecta al tratamiento de datos personales y a la libre circulación de estos datos y por el que se deroga la Directiva 95/46/CE (Reglamento general de protección de datos). DOUE núm. 119, de 4 de mayo de 2016, páginas 1 a 88.
15. World Medical Association: WMA. Código Internacional de Ética Médica. Adoptado por la 3ª Asamblea General de la AMM Londres, Inglaterra, octubre de 1949 y enmendado por la 22ª Asamblea Médica Mundial Sydney, Australia, agosto de 1968, la 35ª Asamblea Médica Mundial Venecia, Italia, octubre de 1983 y la 57 Asamblea General de la AMM, Pilanesberg, Sudáfrica, octubre de 2006.
16. Cauza E, Maier-Dobersberger T, Polli C, et al. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol 1997;27:358-62.
17. Hagström H, Talbäck M, Andreasson A, et al. Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease. J Hepatol 2020;73:1023-9.
18. Llaneras L, Barreira-Díaz A, Rando A, et al. Hacia un hospital libre de hepatitis C: resultados del cribado de la hepatitis C en el servicio de Urgencias de un hospital de tercer nivel. 46º Congreso Anual de la Asociación Española para el Estudio del Hígado. Madrid, 14-16 de junio de 2021.
19. Gómez-Camarero J, Saiz-Chumillas RM, Quiñones R, et al. Hepatitis B and C screening in hospitalized SARS-CoV-2 patients. The International Liver Congress (EASL). 23-26 de junio de 2021.
20. Hernández-Bustabad A, Morales-Arráez D, Reygosa C, et al. The best strategy for retrieval of hepatitis C patients lost to follow up: randomized clinical trial. The International Liver Congress (EASL). 27-29 de agosto de 2020.
Related articles

Original

Active search for hepatitis C patients in primary care

DOI: 10.17235/reed.2021.8067/2021

Original

Hepatitis C in homeless people: reaching a hard-to-reach population

DOI: 10.17235/reed.2021.7737/2020

Editorial

Screening guide for hepatitis C virus infection in Spain

DOI: 10.17235/reed.2020.7728/2020

Special Article

Strategy for the Elimination of Hepatitis C in Cantabria

DOI: 10.17235/reed.2020.7108/2020

Editorial

Reflex testing. A key tool for the elimination of hepatitis C

DOI: 10.17235/reed.2020.7201/2020

Original

Quality of life study in asymptomatic patients with hepatitis C

DOI: 10.17235/reed.2019.6339/2019

Letter

Acute seronegative hepatitis C: two case reports

DOI: 10.17235/reed.2019.5921/2018

Case Report

The clinical extremes of autoimmune cholangitis

DOI: 10.17235/reed.2017.4167/2015

Citation tools
Olveira A, Hernández-Guerra M, Molina E. Cases of liver disease lost in the health system: a call to action. 8316/2021


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1052 visits.
This article has been downloaded 165 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 30/08/2021

Accepted: 14/09/2021

Online First: 30/09/2021

Published: 09/12/2021

Article Online First time: 31 days

Article editing time: 101 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology